Literature DB >> 11958777

Reduced volume of orbitofrontal cortex in major depression.

J Douglas Bremner1, Meena Vythilingam, Eric Vermetten, Ahsan Nazeer, Jahangir Adil, Sarfraz Khan, Lawrence H Staib, Dennis S Charney.   

Abstract

BACKGROUND: Functional neuroimaging studies have implicated dysfunction of orbitofrontal cortex in the symptoms of depression, and a recent postmortem study of depressed patients found reduced density of neurons and glia in this area. The purpose of this study was to measure volume of orbitofrontal cortex and other frontal cortical subregions in patients with major depression.
METHODS: Magnetic resonance imaging was used to measure volume of the orbitofrontal cortex and other frontal cortical regions in patients with major depression in remission (n = 15) and comparison subjects (n = 20).
RESULTS: Patients with depression had a statistically significant 32% smaller medial orbitofrontal (gyrus rectus) cortical volume, without smaller volumes of other frontal regions including anterior cingulate Brodmann's area 24 (subgenual gyrus), anterior cingulate Brodmann's area 32, subcallosal gyrus (Brodmann's area 25), or whole brain volume. The findings were significant after statistically controlling for brain size.
CONCLUSIONS: These findings are consistent with smaller orbitofrontal cortical volume in depression.

Entities:  

Mesh:

Year:  2002        PMID: 11958777     DOI: 10.1016/s0006-3223(01)01336-1

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  155 in total

Review 1.  Interoceptive dysfunction: toward an integrated framework for understanding somatic and affective disturbance in depression.

Authors:  Christopher Harshaw
Journal:  Psychol Bull       Date:  2014-11-03       Impact factor: 17.737

2.  3-D cytoarchitectonic parcellation of human orbitofrontal cortex correlation with postmortem MRI.

Authors:  Harry B M Uylings; Ernesto J Sanz-Arigita; Koos de Vos; Chris W Pool; Paul Evers; Grazyna Rajkowska
Journal:  Psychiatry Res       Date:  2010-06-09       Impact factor: 3.222

3.  A single subanesthetic dose of ketamine relieves depression-like behaviors induced by neuropathic pain in rats.

Authors:  Jing Wang; Yossef Goffer; Duo Xu; David S Tukey; D B Shamir; Sarah E Eberle; Anthony H Zou; Thomas J J Blanck; Edward B Ziff
Journal:  Anesthesiology       Date:  2011-10       Impact factor: 7.892

Review 4.  Neurocognitive elements of antisocial behavior: Relevance of an orbitofrontal cortex account.

Authors:  Jean R Séguin
Journal:  Brain Cogn       Date:  2004-06       Impact factor: 2.310

Review 5.  [Value of diagnostic imaging in evaluation of electroconvulsive therapy].

Authors:  T Frodl; E M Meisenzahl; H-J Möller
Journal:  Nervenarzt       Date:  2004-03       Impact factor: 1.214

Review 6.  Frontocingulate dysfunction in depression: toward biomarkers of treatment response.

Authors:  Diego A Pizzagalli
Journal:  Neuropsychopharmacology       Date:  2010-09-22       Impact factor: 7.853

7.  Cortical thickness predicts the first onset of major depression in adolescence.

Authors:  Lara C Foland-Ross; Matthew D Sacchet; Gautam Prasad; Brooke Gilbert; Paul M Thompson; Ian H Gotlib
Journal:  Int J Dev Neurosci       Date:  2015-08-24       Impact factor: 2.457

Review 8.  Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression.

Authors:  P Licznerski; R S Duman
Journal:  Neuroscience       Date:  2012-10-02       Impact factor: 3.590

9.  Glutamine deficiency in the prefrontal cortex increases depressive-like behaviours in male mice.

Authors:  Younghyurk Lee; Hyeonwi Son; Gyeongwha Kim; Sujeong Kim; Dong Hoon Lee; Gu Seob Roh; Sang Soo Kang; Gyeong Jae Cho; Wan Sung Choi; Hyun Joon Kim
Journal:  J Psychiatry Neurosci       Date:  2013-05       Impact factor: 6.186

10.  The C677T variant in MTHFR modulates associations between brain integrity, mood, and cognitive functioning in old age.

Authors:  Florence F Roussotte; Xue Hua; Katherine L Narr; Gary W Small; Paul M Thompson
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.